DOP2003000655A - PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO - Google Patents
PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACOInfo
- Publication number
- DOP2003000655A DOP2003000655A DO2003000655A DO2003000655A DOP2003000655A DO P2003000655 A DOP2003000655 A DO P2003000655A DO 2003000655 A DO2003000655 A DO 2003000655A DO 2003000655 A DO2003000655 A DO 2003000655A DO P2003000655 A DOP2003000655 A DO P2003000655A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- distribution
- farmaco
- pharmaceutical composition
- uniform power
- active ingredient
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- GXESHMAMLJKROZ-IAPPQJPRSA-N lasofoxifene Chemical compound C1([C@@H]2[C@@H](C3=CC=C(C=C3CC2)O)C=2C=CC(OCCN3CCCC3)=CC=2)=CC=CC=C1 GXESHMAMLJKROZ-IAPPQJPRSA-N 0.000 abstract 1
- 229960002367 lasofoxifene Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 238000009827 uniform distribution Methods 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen composiciones farmacéuticas que poseen una distribución y potencia de fármaco uniforme, que utilizan lasofoxifeno como ingrediente activo, y que contienen un dióxido de silicio para reducir la perdida de ingrediente activo durante el proceso de fabricación, y método para fabricar estas composiciones.Pharmaceutical compositions are described which have a uniform distribution and potency of drug, which use lasofoxifene as an active ingredient, and which contain a silicon dioxide to reduce the loss of active ingredient during the manufacturing process, and method of manufacturing these compositions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2003000655A DOP2003000655A (en) | 2003-06-04 | 2003-06-04 | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2003000655A DOP2003000655A (en) | 2003-06-04 | 2003-06-04 | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2003000655A true DOP2003000655A (en) | 2004-01-31 |
Family
ID=44261189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2003000655A DOP2003000655A (en) | 2003-06-04 | 2003-06-04 | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2003000655A (en) |
-
2003
- 2003-06-04 DO DO2003000655A patent/DOP2003000655A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055528A (en) | PHARMACEUTICAL COMPOSITION THAT HAS A UNIFORM DISTRIBUTION AND POWER OF FARMACO | |
| ES2525410T3 (en) | Compositions and methods for the treatment of dermal hyperproliferative diseases | |
| EA200701065A1 (en) | INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine | |
| UY29562A1 (en) | AMINO BENZOIL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS | |
| PY0206703A (en) | METHOD FOR MANUFACTURING A LOW-DOSE PHARMACEUTICAL COMPOSITION HAVING UNIFORM DRUG DISTRIBUTION AND POTENCY | |
| CL2011000170A1 (en) | Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation. | |
| HN2004000232A (en) | "PIRROLO DERIVATIVES (3,4-C) PIRAZOL ACTIVE AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM." | |
| ECSP077239A (en) | PHARMACEUTICAL FORMULATION | |
| CR8266A (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| NO20062504L (en) | Compositions and dosage forms for improved absorption | |
| MXPA05010659A (en) | Topical anthelmintic veterinary formulations. | |
| BR0306870A (en) | Oral pharmaceutical composition and method for preparing the same | |
| TW200716628A (en) | Novel compounds | |
| UY30393A1 (en) | SUBSTITUTED DERIVATIVES OF 1-PIPERIDIN-1-IL-1,3-DIHIDRO-2H-BENZIMIDAZOL-2-ONA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| PA8599701A1 (en) | DOSAGE FORMS AND TREATMENT PROCEDURES USING VEGFR INHIBITORS | |
| AR033293A1 (en) | COMPOSITIONS AND METHODS TO INCREASE THE BIODISPONIBILITY OF PHARMACEUTICAL AGENTS | |
| DE60142913D1 (en) | DRUG SOLUTIONS CONTAIN MODAFINIL COMPOUNDS | |
| DK1638582T3 (en) | Use of hyaluronic acid for the preparation of compositions for the treatment of recurrent seizures | |
| GT200500113A (en) | PIRIMIDINE DERIVATIVES TO TREAT ANOMALO CELLULAR GROWTH | |
| AR064152A1 (en) | ANTIBACTERIAL QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PREPARATION METHOD. | |
| DOP2003000655A (en) | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO | |
| MX2009008813A (en) | PHARMACEUTICAL COMPOSITION CONTAINING FLOROGLUCINOL AND PARACETAMOL. | |
| DK1537132T3 (en) | Salt of Mortin-6-Glucuronide | |
| RU2008115908A (en) | PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIDASE AND LIPOSOMES FOR EXTERNAL USE | |
| BRPI0507985A (en) | piperazine urea derivatives for the treatment of endometriosis |